medRxiv: plasma protein biomarkers or helps screen for Alzheimer's disease

Introduction: Previous proteomics studies have found significant changes in proteins in plasma, serum, and cerebrospinal fluid in AD patients, but none of these studies have obtained accurate, specific and repeatable AD diagnostic markersThis remains a major challenge, but recent reports suggest that blood biomarkers are possibleresearchers had earlier discovered changes in aprons of blood samples associated with ADThe researchers observed that the strength of the markers is not only affected by the disease, but also by age, sex, and APOE genotypes, which are known to be associated with the risk of ADrecently, researchers at the Floridian Institute of Neuroscience and Mental Health and the Alzheimer's Research Centre at the University of Melbourne published a new study on the preprinted website medRxivThe study aims to identify proteins that are differently expressed in plasma, thus providing a blood screening tool for ADThe study showed that peripheral protein signals may contribute to early diagnosis of AD, and the researchers found a significant correlation between protein levels and APOE genotypes, suggesting that differences in genotype affect circulatory abundance of proteins other than APOEResearchers in Australia conducted imaging, biomarker and lifestyle-related studies (AIBL) to help with the discovery of three biomarkersThe researchers reported an analysis of the initial plasma samples from a gender matching cohort of 72 potential AD patients and 72 healthy controls at the baseline point of aIBLthe group was divided into three groups: cognitively healthy people (health control group, HC), participants who were diagnosed with AD through the NINCDS-ADRDA standard, and participants who were diagnosed with AD with amyloidParticipant recruitment, queue design, and clinical evaluation were previously describedDue to the limitation of sample throughput, the researchers grouped samples for each diagnostic category togetherThe university's ethics committee on human research approved the studyresearchers collected them plasma and then went through a large amount of immune depletion and fractionationThey selected the individual's plasma to thaw on the ice for 1 hour based on gender and disease status (pictured below)Centrifuge the plasma at 16500 x g for 2 min, mixing each person's 50 microliters to produce the final mixed sample Separate EDTA plasma pools were prepared from the subjects in the male AD (mAD), female AD (fAD), male health control group (mHC) and female health control group (fHC) Significant variations in lipoprotein E (APOE), binding beadsin, alpha1-antitrypsin, inter-alpha trypsin inhibitors, and proteins rich in histhain glycoprotein and unknown properties were significantly varied Alpha1 antitrypsin and alpha1 anti-pancreatic lactoproteinase show that plasma concentrations depend on the dose of the APOE e4 allele The analysis also found a correlation between sex and vitamin D binding protein fragments and tonic factor I levels The researchers then validated a single sample using a targeted LC-MS/MS analysis method The results show that peripheral protein may increase the value of plasma amyloid protein detection for early diagnosis of AD